Diversity of crystal structures and physicochemical properties of ciprofloxacin and norfloxacin salts with fumaric acid
暂无分享,去创建一个
[1] H. Mesallati,et al. Polymer/Amorphous Salt Solid Dispersions of Ciprofloxacin , 2017, Pharmaceutical Research.
[2] Z. Finta,et al. Crystallisation of a salt hydrate with a complex solid form landscape , 2017 .
[3] G. Perlovich,et al. Three Polymorphic Forms of Ciprofloxacin Maleate: Formation Pathways, Crystal Structures, Calculations, and Thermodynamic Stability Aspects , 2016 .
[4] H. Mesallati,et al. Two Faces of Ciprofloxacin: Investigation of Proton Transfer in Solid State Transformations , 2016 .
[5] G. Desiraju,et al. A Drug-Drug Salt Hydrate of Norfloxacin and Sulfathiazole: Enhancement of in Vitro Biological Properties via Improved Physicochemical Properties. , 2016, Molecular pharmaceutics.
[6] U. Griesser,et al. Stoichiometric and Nonstoichiometric Hydrates of Brucine , 2016, Crystal growth & design.
[7] S. Mandal,et al. Ciprofloxacin Hippurate Salt: Crystallization Tactics, Structural Aspects, and Biopharmaceutical Performance , 2016 .
[8] A. Matzger,et al. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid. , 2016, Molecular pharmaceutics.
[9] Yang Lu,et al. Salt screening and characterization of ciprofloxacin. , 2016, Acta crystallographica Section B, Structural science, crystal engineering and materials.
[10] A. P. Voronin,et al. Pharmaceutical salts of ciprofloxacin with dicarboxylic acids. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] X. Mei,et al. Supramolecular structures and physicochemical properties of norfloxacin salts. , 2014, Acta crystallographica Section B, Structural science, crystal engineering and materials.
[12] P. Bag,et al. Drug–drug salt forms of ciprofloxacin with diflunisal and indoprofen , 2014 .
[13] I. Marrucho,et al. Novel organic salts based on fluoroquinolone drugs: synthesis, bioavailability and toxicological profiles. , 2014, International journal of pharmaceutics.
[14] Di Zhang,et al. Sorption and solubility of ofloxacin and norfloxacin in water-methanol cosolvent. , 2014, Chemosphere.
[15] A. Healy,et al. Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid. , 2013, Molecular pharmaceutics.
[16] Yonghong Hu,et al. Solubility of Fumaric Acid in Aqueous Alcohol Solutions , 2013, Journal of Solution Chemistry.
[17] S. Price,et al. Absorbing a Little Water: The Structural, Thermodynamic, and Kinetic Relationship between Pyrogallol and Its Tetarto-Hydrate , 2013, Crystal growth & design.
[18] M. Du,et al. Norfloxacin salts with benzenedicarboxylic acids: charge-assisted hydrogen-bonding recognition and solubility regulation , 2013 .
[19] A. Straathof,et al. Solubility of Fumaric Acid and Its Monosodium Salt , 2013 .
[20] S. Velaga,et al. Pharmaceutical Salts of Fluoroquinolone Antibacterial Drugs with Acesulfame Sweetener , 2012 .
[21] S. Black,et al. How To Crystallize Anhydrous Racemic Tartaric Acid from an Ethanol–Water Solution , 2012 .
[22] K. A. Kumar,et al. Fluoroquinolone salts with carboxylic acids. , 2011, Journal of pharmaceutical sciences.
[23] Ashwini Nangia,et al. Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals , 2011 .
[24] S Gaisford,et al. Solid State Characterization of Pharmaceuticals , 2011 .
[25] J. Rantanen,et al. Factors affecting crystallization of hydrates , 2010, The Journal of pharmacy and pharmacology.
[26] M. Garland,et al. Crystallographic, thermal and spectroscopic characterization of a ciprofloxacin saccharinate polymorph. , 2010, International journal of pharmaceutics.
[27] S. Yalkowsky,et al. Handbook of Aqueous Solubility Data, Second Edition , 2010 .
[28] Michael J. Zaworotko,et al. Structure―Stability Relationships in Cocrystal Hydrates: Does the Promiscuity of Water Make Crystalline Hydrates the Nemesis of Crystal Engineering? , 2010 .
[29] R. Manzo,et al. Characterization of the solubility and solid-state properties of saccharin salts of fluoroquinolones. , 2009, Journal of pharmaceutical sciences.
[30] R. Manzo,et al. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. , 2009, International journal of pharmaceutics.
[31] Richard J. Gildea,et al. OLEX2: a complete structure solution, refinement and analysis program , 2009 .
[32] Naír Rodríguez-Hornedo,et al. Role of Cocrystal and Solution Chemistry on the Formation and Stability of Cocrystals with Different Stoichiometry , 2009 .
[33] S. Velaga,et al. Norfloxacin saccharinate-saccharin dihydrate cocrystal : a new pharmaceutical cocrystal with an organic counter ion , 2008 .
[34] I. Marrucho,et al. Solubility of Antibiotics in Different Solvents. Part II. Non-Hydrochloride Forms of Tetracycline and Ciprofloxacin , 2008 .
[35] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[36] Jennifer B Dressman,et al. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database. , 2007, Journal of medicinal chemistry.
[37] Dan Boström,et al. Pharmaceutical Cocrystal and Salts of Norfloxacin , 2006 .
[38] P. Tulkens,et al. Quinolones in 2005: an update. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[39] Xuanqiang Yu,et al. The Effect of Temperature and pH on the Solubility of Quinolone Compounds: Estimation of Heat of Fusion , 1994, Pharmaceutical Research.
[40] A. MacGowan,et al. Development of the quinolones. , 2003, The Journal of antimicrobial chemotherapy.
[41] J. Keith Guillory,et al. Handbook of Pharmaceutical Salts: Properties, Selection, and Use Edited by P. Heinrich Stahl and Camile G. Wermuth. VHCA, Verlag Helvetica Chimica Acta, Zürich, Switzerland, and Wiley-VCH, Weinheim, Germany. 2002. vix + 374 pp. 17.5 × 24.5 cm. ISBN 3-906390-26-8. $130.00 , 2003 .
[42] M. Caira,et al. Structural relationships, thermal properties, and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim. , 2002, Journal of pharmaceutical sciences.
[43] D. Grant,et al. Research paperInfluence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase. 1. Theophylline , 1996 .
[44] D. Grant,et al. Influence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase. 2. Ampicillin , 1996 .
[45] Raymond E. Davis,et al. Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .
[46] C. Riley,et al. Aqueous solubilities of some variously substituted quinolone antimicrobials , 1990 .
[47] M. C. Etter. Encoding and decoding hydrogen-bond patterns of organic compounds , 1990 .
[48] David J.W. Grant,et al. Solubility behavior of organic compounds , 1990 .
[49] S. Z. Mikhail,et al. Densities and Viscosities of Methanol-Water Mixtures. , 1961 .